ASRT Company Profile and Key Details

Q: Who are the executives of ASRT?

Mr. Daniel A. PeisertPres, Chief Executive Officer & DirectorMr. Bill IskosSenior Vice President of OperationsMr. Ajay PatelSenior Vice President & Chief Accounting OfficerMr. Paul SchwichtenbergSenior Vice President & Chief Financial OfficerMr. Sam SchlessingerSenior Vice President & Gen. CounselMr. Jeff ChristensenSenior Vice President of Commercial

NASDAQ : ASRT

Assertio

$11.77

0.11+0.94%

At Close 4:00 PM

71.63

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Assertio Holdings, Inc. (ASRT) stock surged +0.94%, trading at $11.77 on NASDAQ, up from the previous close of $11.66. The stock opened at $11.79, fluctuating between $11.72 and $11.94 in the recent session.

Stock Snapshot

11.66

Prev. Close

75.53M

Market Cap

11.715

Day Low

-2.62

P/E Ratio

-4.5

EPS (TTM)

0.52

Cash Flow per Share

11.79

Open

6.42M

Number of Shares

11.94

Day High

88.98%

Free Float in %

1.46

Book Value

37.58K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 02, 2026	11.82	11.94	11.72	11.77	46.02K
Feb 27, 2026	11.92	12.23	11.60	11.66	45.27K
Feb 26, 2026	11.88	12.08	11.70	11.97	16.93K
Feb 25, 2026	12.00	12.16	11.82	11.85	25.81K
Feb 24, 2026	11.93	12.20	11.82	11.94	23.57K
Feb 23, 2026	11.74	12.08	11.64	12.04	22.69K
Feb 20, 2026	12.00	12.19	11.71	11.84	22.46K
Feb 19, 2026	11.83	12.19	11.65	12.06	24.73K
Feb 18, 2026	12.02	12.19	11.70	11.87	15.56K
Feb 17, 2026	12.23	12.34	11.82	12.05	31.88K
Feb 13, 2026	12.34	12.53	11.95	12.38	53.56K
Feb 12, 2026	12.02	12.30	11.56	12.21	44.36K
Feb 11, 2026	11.63	11.99	11.60	11.95	16.99K
Feb 10, 2026	12.13	12.31	11.43	11.68	83.09K
Feb 09, 2026	12.63	12.75	11.92	12.02	60.09K
Feb 06, 2026	11.69	12.95	11.61	12.74	60.74K
Feb 05, 2026	11.65	11.86	11.43	11.62	69.83K
Feb 04, 2026	11.89	12.02	11.50	11.85	24.17K
Feb 03, 2026	12.28	12.49	11.69	11.99	46.32K
Feb 02, 2026	11.67	12.36	11.67	12.24	37.77K

Contact Details

Lake Forest, IL 60045

United States

https://www.assertiotx.com 224 419 7106

About Company

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Stock Peers

NBIX

0.13+0.10%

Neurocrine Biosciences, Inc.$132.38 ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

1.39+1.86%

Lantheus Holdings, Inc.$76.30 ANIP

1.32+1.79%

ANI Pharmaceuticals, Inc.$75.22 SUPN

0.36+0.66%

Supernus Pharmaceuticals, Inc.$55.09 PAHC

-0.04999924-0.09%

Phibro Animal Health Corporation$54.54 HROW

-0.59-1.09%

Harrow Health, Inc.$53.59 COLL

-0.07-0.17%

Collegium Pharmaceutical, Inc.$41.60 INDV

-0.74-2.26%

Indivior Pharmaceuticals Inc$31.98 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98

Company Overview

Assertio Holdings, Inc. (NASDAQ:ASRT) closed at $11.77 USD, gaining $0.11 (0.94%) from the previous close of $11.66. The stock is currently mid-range between its 52-week high and low $7.65 and $15.15. With a market capitalization of about $75.53 million, Assertio Holdings, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.73). Key stats such as the average daily volume over the past year has been around 47.67 thousand shares, in line with its 52-week average. Headquartered in Lake Forest, IL, Assertio Holdings, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Mark L. Reisenauer, the company employs approximately 58 people and listed since December 03, 1997. Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation.

Technical Performance

ASRT has shown mixed momentum, gaining 25.43% over the past week and -2.61% over the past quarter, though year-to-date performance is up 28.89%. Short-term trend indicators are mixed aligned (SMA20 -0.17%, SMA50 8.01%, SMA200 6.04%). The stock’s 14-day RSI is 53.3 (neutral), while the ATR of 0.58 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -20.99% below its high and over 55.34% above its low. Average 10-day trading volume of 28.96 thousand shares is below the 3-month average of 41.14 thousand, indicating normal recent market interest.

Valuation Metrics

Assertio Holdings, Inc. trades at a P/E ratio of -2.6, slightly below the S&P 500 average, with a price-to-sales ratio of 0.55 and a price-to-book ratio of 0.71 suggesting the stock is closer to book value. The P/FCF stands at 5.65, also above market averages.

Dividend & Fair Value

Assertio Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $36.83. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Assertio Holdings, Inc. generated EPS of -$4.71 over the past year. Five-year average earnings growth is 55.01%. The latest quarter delivered EPS of $0.11. The next quarter is forecast at -$3.12. Next year's EPS is expected at -$70.33. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $35.00 to $3.00. The high target offers 197.37% upside. The low target suggests -74.51% downside. The mean target is $13.83. This offers 17.5% upside. Assertio Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended November 10, 2025, missed forecasts by -237.5%. The prior quarter beat by 70.0%. Over the last six quarters, Apple has recorded several small beats. These include 25.0% in August 07, 2024.

Shareholding & Insider Activity

Assertio Holdings, Inc. has 6.42 million shares outstanding. The public float is 5.70 million shares, elevated short interest at 4.02% of float. This equals 255.62 thousand shares. The short ratio is 4.89 days. Institutional investors hold 27.84% of the float. Insiders own 2.5%. Peisert Daniel A. holds 324.94 thousand shares, Mason Heather L has 287.65 thousand shares and MCKEE WILLIAM has 238.78 thousand shares. Over the past six months, insider transactions show net selling. They sold 8.96 thousand shares across 1 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Assertio generated $152.07M in revenue, or $2.14 per share. Gross margin was 63.67%, operating margin 16.40%, and net profit margin -218.28%. Returns are negative, with ROA at -115.89% and ROE at -240.53%.
On valuation metrics, Assertio trades at a P/E of -2.60, P/S of 0.55 and P/B of 0.71. The current ratio is 1.58 and quick ratio is 1.43. Operationally, the company’s inventory turnover is 1.77 and cash conversion cycle is 459.81 days. Debt-to-equity is 0.37, supported by a cash flow-to-debt ratio of 0.34.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Assertio posted revenue of $152.07M, down slightly from $156.23M in the prior quarter. Gross profit was $96.82M (margin 63.67%). Operating income was $24.94M (margin 16.4%). Net income was- $331.94M (EPS - $4.67).
The company ended the quarter with $73.44M in cash and short-term investments, a total debt of $40.91M, and net debt of - $32.53M. Total assets were $286.42M, with equity of $138.00M. Financials further reflected stability, with operating cash flow of $49.60M, free cash flow of $48.98M, and capital expenditures of - $628.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Assertio Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.02%, with price expected at $11.89 by March 13, 2026, within a range of $11.47 to $12.31 3-Month Outlook: Projected fall of -64.23%, reaching $4.21 by May 28, 2026, with a range of $0.00 to $9.78. 1-Year Outlook: Projected loss of -64.91%, with price at $4.13 by February 26, 2027, within a range of $0.00 to $22.43.

Key Takeaways

Assertio Holdings, Inc. (NASDAQ:ASRT) shares are up 28.89% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Assertio Holdings, Inc. trading at a premium to the broader market with a P/E of -2.6. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $7.86, suggesting -33.22% downside. Our AI forecast model points to short-term strength (1.02% over two weeks), a medium-term fall (-64.23% over three months), and a longer-term loss (-64.91% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Assertio Holdings, Inc. (ASRT) stock price?

Assertio Holdings, Inc. (NASDAQ: ASRT) stock price is $11.77 in the last trading session. During the trading session, ASRT stock reached the peak price of $11.94 while $11.72 was the lowest point it dropped to. The percentage change in ASRT stock occurred in the recent session was 0.94% while the dollar amount for the price change in ASRT stock was $0.11.

ASRT's industry and sector of operation?

The NASDAQ listed ASRT is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Assertio Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ASRT?

Mr. Daniel A. Peisert
Pres, Chief Executive Officer & Director
Mr. Bill Iskos
Senior Vice President of Operations
Mr. Ajay Patel
Senior Vice President & Chief Accounting Officer
Mr. Paul Schwichtenberg
Senior Vice President & Chief Financial Officer
Mr. Sam Schlessinger
Senior Vice President & Gen. Counsel
Mr. Jeff Christensen
Senior Vice President of Commercial

How ASRT did perform over past 52-week?

ASRT's closing price is 53.86% higher than its 52-week low of $7.65 where as its distance from 52-week high of $15.15 is -22.31%.

How many employees does ASRT have?

Number of ASRT employees currently stands at 58.

Link for ASRT official website?

Official Website of ASRT is: https://www.assertiotx.com

How do I contact ASRT?

ASRT could be contacted at phone 224 419 7106 and can also be accessed through its website. ASRT operates from 100 South Saunders Road, Lake Forest, IL 60045, United States.

How many shares of ASRT are traded daily?

ASRT stock volume for the day was 37.58K shares. The average number of ASRT shares traded daily for last 3 months was 47.67K.

What is the market cap of ASRT currently?

The market value of ASRT currently stands at $75.53M with its latest stock price at $11.77 and 6.42M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	58
Beta	0.73
Sales or Revenue	$152.07M
5Y Sales Change%	-0.89%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

ASRT Company Profile and Key Details

Assertio

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics